Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Challenging Cases in the Clinic

How confident are you at identifying patients with hormone receptor (HR)-positive/ human epidermal growth factor receptor 2 (HER2)-negative early breast cancer at high risk of recurrence? Credit available for this activity expires: 11/28/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983866?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Nov 28, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Challenging Cases in the Clinic

0:00 31:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 31 minutes long.

When was this Keeping Current CME episode published?

This episode was published on November 28, 2022.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!